🎉 M&A multiples are live!
Check it out!

Zura Bio Valuation Multiples

Discover revenue and EBITDA valuation multiples for Zura Bio and similar public comparables like Vivoryon Therapeutics, Julphar, and Pharming.

Zura Bio Overview

About Zura Bio

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.


Founded

2022

HQ

United States of America
Employees

30

Website

zurabio.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

-$99.9M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Zura Bio Financials

Zura Bio has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Zura Bio achieved revenue of n/a and an EBITDA of -$55.2M.

Zura Bio expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Zura Bio valuation multiples based on analyst estimates

Zura Bio P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$62.6M -$55.2M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit $3.5M -$60.4M XXX XXX XXX
Net Margin Infinity% -Infinity% XXX XXX XXX
Net Debt $0.3M n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Zura Bio Stock Performance

As of April 15, 2025, Zura Bio's stock price is $1.

Zura Bio has current market cap of $76.6M, and EV of -$99.9M.

See Zura Bio trading valuation data

Zura Bio Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
-$99.9M $76.6M XXX XXX XXX XXX $-0.62

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Zura Bio Valuation Multiples

As of April 15, 2025, Zura Bio has market cap of $76.6M and EV of -$99.9M.

Zura Bio's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Zura Bio's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Zura Bio and 10K+ public comps

Zura Bio Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV -$99.9M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA 1.8x XXX XXX XXX
P/E -1.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 3.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Zura Bio Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Zura Bio Valuation Multiples

Zura Bio's NTM/LTM revenue growth is n/a

Zura Bio's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.8M for the same period.

Over next 12 months, Zura Bio's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Zura Bio's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Zura Bio and other 10K+ public comps

Zura Bio Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -12% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.8M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Zura Bio Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Zura Bio M&A and Investment Activity

Zura Bio acquired  XXX companies to date.

Last acquisition by Zura Bio was  XXXXXXXX, XXXXX XXXXX XXXXXX . Zura Bio acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Zura Bio

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Zura Bio

When was Zura Bio founded? Zura Bio was founded in 2022.
Where is Zura Bio headquartered? Zura Bio is headquartered in United States of America.
How many employees does Zura Bio have? As of today, Zura Bio has 30 employees.
Who is the CEO of Zura Bio? Zura Bio's CEO is Mr. Robert Lisicki.
Is Zura Bio publicy listed? Yes, Zura Bio is a public company listed on NAS.
What is the stock symbol of Zura Bio? Zura Bio trades under ZURA ticker.
When did Zura Bio go public? Zura Bio went public in 2023.
Who are competitors of Zura Bio? Similar companies to Zura Bio include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Zura Bio? Zura Bio's current market cap is $76.6M
Is Zura Bio profitable? Yes, Zura Bio is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.